TrialDiabetes, obesity & metabolism2018

Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects.

Michael F Crutchlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.